Vogenx, Inc.
Research Vogenx, Inc. (VOGX) on Bullrun: market cap USD 215.84M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVOGX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 215.84M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 384.43K
- Free cash flowUSD 27.14K
Valuation Snapshot
latest market cap is USD 215.84M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 1.45M | -USD 1.11M | n/a | n/a | USD 601.01K | USD 816.30K | -USD 919.24K |
| FY2024 | USD 0 | -USD 2.20M | -USD 2.34M | n/a | -0.29 | USD 962.92K | n/a | USD 509.58K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 215.84M | n/a | n/a | n/a |
About Vogenx, Inc.
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vogenx, Inc.'s market cap?
Vogenx, Inc.'s market capitalization is USD 215.84M.
What does Vogenx, Inc. do?
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.